# BIOMARIN PHARMACEUTICAL INC > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:fb318172-dd09-4884-bbb7-db38da2131a8 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/biomarin-pharmaceutical-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 35 | | Claims under review | 1 | | Evidence records | 13 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-16T04:45:34.558203+00:00 | | Last reviewed | 2026-10-16T04:45:34.558203+00:00 | ## Identity - Legal name: BIOMARIN PHARMACEUTICAL INC - Display name: BIOMARIN PHARMACEUTICAL INC ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-16T13:07:27.372662+00:00 | | Completeness | 0.409 | | Record Quality | 0.838 | | Directors | 10 | | Committees | 6 | | Governance events | 25 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Adrian Hardy: Director. Status: current. Independent: false. Since: 2023-01-01. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:6 - Athena Countouriotis: Director. Status: current. Independent: true. Since: 2023-01-01. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:7 - Barbara W. Bodem: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (member). claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:8 - Elizabeth McKee Anderson: Director. Status: current. Independent: true. Since: 2019-01-01. Committees: Compensation (chair); Compensation · Chair (member). claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:9 - Ian T. Clark: Director. Status: current. Independent: true. Since: 2025-01-01. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:10 - Mark Enyedy: Director. Status: current. Independent: true. Since: 2023-01-01. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:11 - Maykin Ho: Director. Status: current. Independent: true. Since: 2021-01-01. Committees: Audit (member). claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:12 - Robert J. Hombach: Director. Status: current. Independent: true. Since: 2017-01-01. Committees: Audit (chair); Audit · Chair (member). claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:13 - Timothy P. Walbert: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Compensation (member); Compensation; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:14 - Willard Dere: Director. Status: current. Independent: true. Since: 2016-01-01. Committees: Nominating and Governance (member). claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:15 ## Committees - Audit (audit). Chair: Robert J. Hombach. Members: Robert J. Hombach (chair, current); Barbara W. Bodem (member, current); Maykin Ho (member, current). committee_id=alpha:committee:biomarin-pharmaceutical-inc:audit - Audit · Chair (audit). Chair: NOT_PUBLISHED. Members: Robert J. Hombach (member, current). committee_id=alpha:committee:biomarin-pharmaceutical-inc:audit-chair - Compensation (compensation). Chair: Elizabeth McKee Anderson. Members: Elizabeth McKee Anderson (chair, current); Timothy P. Walbert (member, current). committee_id=alpha:committee:biomarin-pharmaceutical-inc:compensation - Compensation · Chair (compensation). Chair: NOT_PUBLISHED. Members: Elizabeth McKee Anderson (member, current). committee_id=alpha:committee:biomarin-pharmaceutical-inc:compensation-chair - Compensation; Nominating and Governance (compensation). Chair: NOT_PUBLISHED. Members: Timothy P. Walbert (member, current). committee_id=alpha:committee:biomarin-pharmaceutical-inc:compensation-nominating-and-governance - Nominating and Governance (nominating_governance). Chair: NOT_PUBLISHED. Members: Timothy P. Walbert (member, current); Willard Dere (member, current). committee_id=alpha:committee:biomarin-pharmaceutical-inc:nominating-and-governance ## Executive leadership - Adrian Hardy: President and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:16 - Alexander Hardy: President and Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:17 - Brian R. Mueller: Executive Vice President and Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:18 - C. Greg Guyer: Executive Vice President and Chief Technical Officer. Status: current. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:19 - Cristin Hubbard: Executive Vice President and Chief Commercial Officer. Status: current. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:20 - George S. Davis: Executive Vice President, Chief Legal Officer and Secretary [GC]. Status: current. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:23 - Gregory R. Friberg: Executive Vice President and Chief Research Development Officer. Status: current. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:24 - Rashmi Ramchandani: Vice President and Chief Accounting Officer [CAO]. Status: current. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:25 - Erin Burkhart: Group Vice President and Chief Accounting Officer [CAO]. Status: unknown. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:21 - G. Eric Davis: Executive Vice President, Chief Legal Officer and Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:22 ## Governance events - CEO_CHANGED: Adrian Hardy executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:10bsjzq13o4ih0 - CEO_CHANGED: Alexander Hardy executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:9f1wel1o9vnht - CFO_CHANGED: Brian R. Mueller executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:xdm6ip16e42u9 - EXECUTIVE_APPOINTED: C. Greg Guyer executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:1e3v2prequzfb - EXECUTIVE_APPOINTED: Cristin Hubbard executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:qg9vqgzrrthu - GC_CHANGED: George S. Davis executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:1x57yp41tmi562 - EXECUTIVE_APPOINTED: Gregory R. Friberg executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:67rpxmwmies8 - EXECUTIVE_APPOINTED: Rashmi Ramchandani executive of BIOMARIN PHARMACEUTICAL INC, effective 2026-04-21. Effective: 2026-04-21. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:yom8pw1xd3fru - DIRECTOR_APPOINTED: Ian T. Clark seat on BIOMARIN PHARMACEUTICAL INC, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:slmkwn8jbhyt - DIRECTOR_APPOINTED: Timothy P. Walbert seat on BIOMARIN PHARMACEUTICAL INC, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:ysoj9fnvv9x5 - COMMITTEE_CREATED: Compensation; Nominating and Governance committee of BIOMARIN PHARMACEUTICAL INC, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:1c7a4hbrcap0p - COMMITTEE_MEMBER_ADDED: Timothy P. Walbert member of Compensation; Nominating and Governance, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:1eoccuv19hibqf - DIRECTOR_APPOINTED: Adrian Hardy seat on BIOMARIN PHARMACEUTICAL INC, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:1ytbvx6ylibus - DIRECTOR_APPOINTED: Athena Countouriotis seat on BIOMARIN PHARMACEUTICAL INC, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:1ckheej16luhfp - DIRECTOR_APPOINTED: Barbara W. Bodem seat on BIOMARIN PHARMACEUTICAL INC, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:12gcmygwmc522 - DIRECTOR_APPOINTED: Mark Enyedy seat on BIOMARIN PHARMACEUTICAL INC, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:1k7gye81y4ax6 - COMMITTEE_MEMBER_ADDED: Barbara W. Bodem member of Audit, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:ioeli1bvnh7v - DIRECTOR_APPOINTED: Maykin Ho seat on BIOMARIN PHARMACEUTICAL INC, effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:17z0sfp1hd8vej - DIRECTOR_APPOINTED: Elizabeth McKee Anderson seat on BIOMARIN PHARMACEUTICAL INC, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:1kx7qpq1d1huza - COMMITTEE_CREATED: Compensation · Chair committee of BIOMARIN PHARMACEUTICAL INC, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:hlb9wm2v5o9y - COMMITTEE_MEMBER_ADDED: Elizabeth McKee Anderson member of Compensation · Chair, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:nhxmic1308wiq - DIRECTOR_APPOINTED: Robert J. Hombach seat on BIOMARIN PHARMACEUTICAL INC, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:3u9xmj1rebxvn - COMMITTEE_CREATED: Audit · Chair committee of BIOMARIN PHARMACEUTICAL INC, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:15daymd6mkw47 - COMMITTEE_MEMBER_ADDED: Robert J. Hombach member of Audit · Chair, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:b1zd9q1lw987m - DIRECTOR_APPOINTED: Willard Dere seat on BIOMARIN PHARMACEUTICAL INC, effective 2016-01-01. Effective: 2016-01-01. Detected: 2026-10-16T04:45:34.558203+00:00. event_id=alpha:event:transition:1z0frgsxsnv38 ## Scoped resources - `alpha://company/biomarin-pharmaceutical-inc` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record - `alpha://company/biomarin-pharmaceutical-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=identity - `alpha://company/biomarin-pharmaceutical-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=corporate-structure - `alpha://company/biomarin-pharmaceutical-inc/board` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=board - `alpha://company/biomarin-pharmaceutical-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=committees - `alpha://company/biomarin-pharmaceutical-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=leadership - `alpha://company/biomarin-pharmaceutical-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=ownership - `alpha://company/biomarin-pharmaceutical-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=financials - `alpha://company/biomarin-pharmaceutical-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=capital-structure - `alpha://company/biomarin-pharmaceutical-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=compensation - `alpha://company/biomarin-pharmaceutical-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=governance - `alpha://company/biomarin-pharmaceutical-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=shareholder-governance - `alpha://company/biomarin-pharmaceutical-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=audit - `alpha://company/biomarin-pharmaceutical-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=legal - `alpha://company/biomarin-pharmaceutical-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=risk - `alpha://company/biomarin-pharmaceutical-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=cyber - `alpha://company/biomarin-pharmaceutical-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=ai-governance - `alpha://company/biomarin-pharmaceutical-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=agents - `alpha://company/biomarin-pharmaceutical-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=ecosystem - `alpha://company/biomarin-pharmaceutical-inc/events` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=events - `alpha://company/biomarin-pharmaceutical-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=relationships - `alpha://company/biomarin-pharmaceutical-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=assessments - `alpha://company/biomarin-pharmaceutical-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:robert-j-hombach","name":"Robert J. Hombach"},"source_id":"board_seats"}` - Claim alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:28: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:barbara-w-bodem","name":"Barbara W. Bodem"},"source_id":"board_seats"}` - Claim alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:29: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:maykin-ho","name":"Maykin Ho"},"source_id":"board_seats"}` - Claim alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:31: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:elizabeth-mckee-anderson","name":"Elizabeth McKee Anderson"},"source_id":"board_seats"}` - Claim alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:32: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:timothy-p-walbert","name":"Timothy P. Walbert"},"source_id":"board_seats"}` - Claim alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:34: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:timothy-p-walbert","name":"Timothy P. Walbert"},"source_id":"board_seats"}` - Claim alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:35: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:willard-dere","name":"Willard Dere"},"source_id":"board_seats"}` ## Leadership - Adrian Hardy: Director. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:6. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b. - Athena Countouriotis: Director. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:7. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b. - Barbara W. Bodem: Director, Audit. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:8. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b. - Elizabeth McKee Anderson: Director, Compensation · Chair. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:9. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b. - Ian T. Clark: Director. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:10. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b. - Mark Enyedy: Director. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:11. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b. - Maykin Ho: Director, Audit. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:12. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b. - Robert J. Hombach: Director, Audit · Chair. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:13. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b. - Timothy P. Walbert: Director, Compensation; Nominating and Governance. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:14. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b. - Willard Dere: Director, Nominating and Governance. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:15. Valid from: 2016-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b. - Adrian Hardy: President and Chief Executive Officer. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:16. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b3598f3e6eda560d83a00f9929a83cc61bd68f09f96aa5c37d826e06902d6ccf. - Alexander Hardy: President and Chief Executive Officer. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:17. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b9594a4aa6be439b3adb396114e1a37caa813bbc904fc7cc39b1525322583957. - Brian R. Mueller: Executive Vice President and Chief Financial Officer. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:18. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5f45c97dfae6a6e2383333577db0ddd9d1ab8eb5c78790fcf2c65bed5b404c65. - C. Greg Guyer: Executive Vice President and Chief Technical Officer. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:19. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:890d97ecd15c01311b5a4638e3242135244cb3d73e8b2179e02cd23655b0dc3c. - Cristin Hubbard: Executive Vice President and Chief Commercial Officer. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:20. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c94a9faf9269f87822325409f687ec8adbfc598b242875c9b808dadd22801e37. - Erin Burkhart: Group Vice President and Chief Accounting Officer. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:8ffe27fdac74e43ddbcafe3b2e4b48e3a87aa42cab0a7e79498d4b4f906a3897. - G. Eric Davis: Executive Vice President, Chief Legal Officer and Secretary. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:624c60829bef719a7ff8952f6d4812bb95faf233edf1304455c3675f1b7f0e91. - George S. Davis: Executive Vice President, Chief Legal Officer and Secretary. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:23. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:3121c99406bd9128465de8ae6050939c26d7b39a2c5e0f37dff1514f939af504. - Gregory R. Friberg: Executive Vice President and Chief Research Development Officer. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:24. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9b441dcc83b81cd5ab5d3f3cd2140e086e130c56013ce7d559e22b12e9cc046c. - Rashmi Ramchandani: Vice President and Chief Accounting Officer. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:leadership_role:25. Valid from: 2026-04-21. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:a6d83333796563896596434ce13073426eff92b856543f6f9e372e576373949f. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Robert J. Hombach; Members Robert J. Hombach (Chair); Barbara W. Bodem; Maykin Ho. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_record:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa. - Compensation: Chair Elizabeth McKee Anderson; Members Elizabeth McKee Anderson (Chair); Timothy P. Walbert. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_record:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa. - Nominating and Governance: Chair not stated; Members Timothy P. Walbert; Willard Dere. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_record:33. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - BIOMARIN PHARMACEUTICAL INC. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:52eaaade9c8cb409e5b2c5bb3d5f3e9e5a159f7257317cec85c485a20a910d15. ## Entity Status - Public listing published. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:52eaaade9c8cb409e5b2c5bb3d5f3e9e5a159f7257317cec85c485a20a910d15. ## Published Fact - US. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:52eaaade9c8cb409e5b2c5bb3d5f3e9e5a159f7257317cec85c485a20a910d15. - Healthcare. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:52eaaade9c8cb409e5b2c5bb3d5f3e9e5a159f7257317cec85c485a20a910d15. ## Committee Appointment - Robert J. Hombach: chair, Audit. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa. - Barbara W. Bodem: member, Audit. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa. - Maykin Ho: member, Audit. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa. - Elizabeth McKee Anderson: chair, Compensation. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa. - Timothy P. Walbert: member, Compensation. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:32. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa. - Timothy P. Walbert: member, Nominating and Governance. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:34. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa. - Willard Dere: member, Nominating and Governance. Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:committee_appointment:35. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa. ## Security Listing - BMRN (NASDAQ). Claim: alpha:claim:company:fb318172-dd09-4884-bbb7-db38da2131a8:security_listing:36. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:52eaaade9c8cb409e5b2c5bb3d5f3e9e5a159f7257317cec85c485a20a910d15. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:52eaaade9c8cb409e5b2c5bb3d5f3e9e5a159f7257317cec85c485a20a910d15: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc). - alpha:projection-evidence:document:93bdbdd53f407667b0c434aa907424f2691d59b26bd02c377fd19798701a686b: [BioMarin Pharmaceutical DEF 14A 2026-04-21](https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm). - alpha:projection-evidence:document:b3598f3e6eda560d83a00f9929a83cc61bd68f09f96aa5c37d826e06902d6ccf: [BMRN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm). - alpha:projection-evidence:document:b9594a4aa6be439b3adb396114e1a37caa813bbc904fc7cc39b1525322583957: [BMRN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm). - alpha:projection-evidence:document:5f45c97dfae6a6e2383333577db0ddd9d1ab8eb5c78790fcf2c65bed5b404c65: [BMRN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm). - alpha:projection-evidence:document:890d97ecd15c01311b5a4638e3242135244cb3d73e8b2179e02cd23655b0dc3c: [BMRN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm). - alpha:projection-evidence:document:c94a9faf9269f87822325409f687ec8adbfc598b242875c9b808dadd22801e37: [BMRN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm). - alpha:projection-evidence:document:8ffe27fdac74e43ddbcafe3b2e4b48e3a87aa42cab0a7e79498d4b4f906a3897: BMRN executive roster source. - alpha:projection-evidence:document:624c60829bef719a7ff8952f6d4812bb95faf233edf1304455c3675f1b7f0e91: BMRN executive roster source. - alpha:projection-evidence:document:3121c99406bd9128465de8ae6050939c26d7b39a2c5e0f37dff1514f939af504: [BMRN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm). - alpha:projection-evidence:document:9b441dcc83b81cd5ab5d3f3cd2140e086e130c56013ce7d559e22b12e9cc046c: [BMRN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm). - alpha:projection-evidence:document:a6d83333796563896596434ce13073426eff92b856543f6f9e372e576373949f: [BMRN DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm). - alpha:projection-evidence:a25b8e211eed7ea4b80085339941077ce8f3de1a7202bf571657a7b39f2545fa: [Audit](https://www.sec.gov/Archives/edgar/data/1048477/000162828026026290/bmrn-20260421.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/biomarin-pharmaceutical-inc) - [Public Markdown](https://registry.alpha.ac/companies/biomarin-pharmaceutical-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/biomarin-pharmaceutical-inc?format=jsonld) - MCP resource: `alpha://companies/biomarin-pharmaceutical-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-16T13:07:27.161686+00:00; recorded 2026-10-16T13:07:27.161686+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.